Pricing Log in Create free account

LENZ Therapeutics, Inc. (LENZ) vs Neumora Therapeutics, Inc. (NMRA)

LENZ Therapeutics, Inc. and Neumora Therapeutics, Inc. are both Biotechnology companies. LENZ Therapeutics, Inc. and Neumora Therapeutics, Inc. are of similar size ($94.6M and $91.5M). Neumora Therapeutics, Inc. has the higher net margin (0.00% vs −1,135.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, LENZ Therapeutics, Inc. leads on 8 and Neumora Therapeutics, Inc. on 5.

Valuation

Metric LENZ NMRA Biotechnology median
P/E n/m n/m 10.26
P/S 7.73 n/m 9.18
P/B 0.50 2.08 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.67 n/m 0.65
EV/Sales (8.06) n/m 8.98
Earnings yield (147.55%) (246.00%) (34.89%)
Free cash flow yield (133.70%) (194.76%) (24.52%)

Profitability

Metric LENZ NMRA Biotechnology median
Gross margin 85.35% 0.00% 65.16%
Operating margin (1,211.17%) 0.00% 0.00%
Net margin (1,134.97%) 0.00% 0.00%
Free cash flow margin (1,033.28%) 0.00% 0.00%
Return on equity (72.69%) (187.11%) (50.12%)
Return on assets (66.72%) (121.89%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LENZ NMRA Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) (21.79%) 5.23% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric LENZ NMRA Biotechnology median
Debt to equity 0.00 1.19 0.00
Current ratio 11.66 4.50 4.89
Net debt to EBITDA 3.22 0.53 1.01

Dividend

Metric LENZ NMRA Biotechnology median
Dividend yield 0.00% — 0.41%
Payout ratio — — —

Size

Metric LENZ NMRA Biotechnology median
Market cap 94.58m 91.51m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack